Looking-glass synergistic pharmacological chaperones: DGJ and L-DGJ from the enantiomers of tagatose

Sarah F. Jenkinson, George W.J. Fleet*, Robert J. Nash, Yuriko Koike, Isao Adachi, Akihide Yoshihara, Kenji Morimoto, Ken Izumori, Atsushi Kato

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

The enantiomers of tagatose are converted to l-DGJ [a noncompetitive inhibitor of human lysosome α-galactosidase A (α-Gal A), K i 38.5 μM] and DGJ [a competitive inhibitor of α-Gal A, K i 15.1 nM] in 66% yield. l-DGJ and DGJ provide the first examples of pharmacological chaperones that (a) are enantiomeric iminosugars and (b) have synergistic activity with implications for the treatment of lysosomal storage disorders and other protein deficiencies.

Original languageEnglish
Pages (from-to)4064-4067
Number of pages4
JournalOrganic Letters
Volume13
Issue number15
DOIs
StatePublished - 2011/08/05

ASJC Scopus subject areas

  • Biochemistry
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Looking-glass synergistic pharmacological chaperones: DGJ and L-DGJ from the enantiomers of tagatose'. Together they form a unique fingerprint.

Cite this